Abstract
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
S M Sorensen, T M Humphreys, V L Taylor and C J Schmidt
Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 872-878;